mesalamine has been researched along with phosphatidylcholines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, LM; Dinis, TC; Gonçalves, E | 1 |
| Dina, I; Karner, M; Keilhauer, G; Kocjan, A; Kupcinskas, L; Schmidt, C; Schreiber, S; Stein, J; Stremmel, W; Uebel, P; von Boyen, G; Zuelch, F | 1 |
1 trial(s) available for mesalamine and phosphatidylcholines
| Article | Year |
|---|---|
First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Double-Blind Method; Female; Germany; Humans; Lithuania; Male; Mesalamine; Middle Aged; Phosphatidylcholines; Placebos; Romania; Treatment Outcome | 2014 |
3 other study(ies) available for mesalamine and phosphatidylcholines
| Article | Year |
|---|---|
Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction?
Topics: Amidines; Antioxidants; Azo Compounds; Chromatography, High Pressure Liquid; Drug Synergism; Free Radical Scavengers; Glycine max; Hydrogen Peroxide; Lipid Peroxidation; Liposomes; Mesalamine; Nitriles; Oxidation-Reduction; Oxygen; Phosphatidylcholines; Vitamin E | 1998 |
[Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
Topics: Administration, Oral; Administration, Rectal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials, Phase II as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Phosphatidylcholines; Pilot Projects; Practice Guidelines as Topic; Remission Induction; Treatment Outcome; Trichuris | 2006 |
[Chronic inflammatory bowel diseases. Strive for healing the mucosa, prevent overtreatment].
Topics: Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Intestinal Mucosa; Mesalamine; Phosphatidylcholines | 2014 |